Engineered cell therapy for cancer gets thumbs up from FDA advisers

    loading  Checking for direct PDF access through Ovid

Abstract

Treatment shows promise in young people with leukaemia, but safety risks abound.

Heidi writes about biology and medicine, and has a PhD from the University of California, Berkeley. Heidi has written for The Oregonian, edited for the Berkeley Science Review, and freelanced for a few other publications.

    loading  Loading Related Articles